175 related articles for article (PubMed ID: 38133688)
1. Automated identification of uncertain cases in deep learning-based classification of dopamine transporter SPECT to improve clinical utility and acceptance.
Budenkotte T; Apostolova I; Opfer R; Krüger J; Klutmann S; Buchert R
Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1333-1344. PubMed ID: 38133688
[TBL] [Abstract][Full Text] [Related]
2. Explainable AI to improve acceptance of convolutional neural networks for automatic classification of dopamine transporter SPECT in the diagnosis of clinically uncertain parkinsonian syndromes.
Nazari M; Kluge A; Apostolova I; Klutmann S; Kimiaei S; Schroeder M; Buchert R
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1176-1186. PubMed ID: 34651223
[TBL] [Abstract][Full Text] [Related]
3. Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies.
McCleery J; Morgan S; Bradley KM; Noel-Storr AH; Ansorge O; Hyde C
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010633. PubMed ID: 25632881
[TBL] [Abstract][Full Text] [Related]
4. Automatic classification of dopamine transporter SPECT: deep convolutional neural networks can be trained to be robust with respect to variable image characteristics.
Wenzel M; Milletari F; Krüger J; Lange C; Schenk M; Apostolova I; Klutmann S; Ehrenburg M; Buchert R
Eur J Nucl Med Mol Imaging; 2019 Dec; 46(13):2800-2811. PubMed ID: 31473800
[TBL] [Abstract][Full Text] [Related]
5. Utility of Follow-up Dopamine Transporter SPECT With 123I-FP-CIT in the Diagnostic Workup of Patients With Clinically Uncertain Parkinsonian Syndrome.
Apostolova I; Taleb DS; Lipp A; Galazky I; Kupitz D; Lange C; Makowski MR; Brenner W; Amthauer H; Plotkin M; Buchert R
Clin Nucl Med; 2017 Aug; 42(8):589-594. PubMed ID: 28574876
[TBL] [Abstract][Full Text] [Related]
6. No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome.
Schiebler T; Apostolova I; Mathies FL; Lange C; Klutmann S; Buchert R
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3302-3312. PubMed ID: 37328621
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.
McKeith I; O'Brien J; Walker Z; Tatsch K; Booij J; Darcourt J; Padovani A; Giubbini R; Bonuccelli U; Volterrani D; Holmes C; Kemp P; Tabet N; Meyer I; Reininger C;
Lancet Neurol; 2007 Apr; 6(4):305-13. PubMed ID: 17362834
[TBL] [Abstract][Full Text] [Related]
8. Measurement of [123I]FP-CIT binding to the dopamine transporter (DAT) in healthy mouse striatum using dedicated small animal SPECT imaging: feasibility, optimization and validation.
Greco A; Zannetti A; Pappatà S; Albanese S; Coda AR; Ragucci M; Nardelli A; Brunetti A; Cuocolo A; Salvatore M
Q J Nucl Med Mol Imaging; 2018 Mar; 62(1):112-117. PubMed ID: 26329495
[TBL] [Abstract][Full Text] [Related]
9. Deep learning regressor model based on nigrosome MRI in Parkinson syndrome effectively predicts striatal dopamine transporter-SPECT uptake.
Bae YJ; Choi BS; Kim JM; Ai WA; Yun I; Song YS; Nam Y; Cho SJ; Kim JH
Neuroradiology; 2023 Jul; 65(7):1101-1109. PubMed ID: 37209181
[TBL] [Abstract][Full Text] [Related]
10. Dopamine Transporter SPECT with 12-Minute Scan Duration Using Multiple-Pinhole Collimators.
Buchert R; Szabo B; Kovacs A; Buddenkotte T; Mathies F; Karimzadeh A; Lehnert W; Klutmann S; Forgacs A; Apostolova I
J Nucl Med; 2024 Mar; 65(3):446-452. PubMed ID: 38238040
[TBL] [Abstract][Full Text] [Related]
11. Data-driven identification of diagnostically useful extrastriatal signal in dopamine transporter SPECT using explainable AI.
Nazari M; Kluge A; Apostolova I; Klutmann S; Kimiaei S; Schroeder M; Buchert R
Sci Rep; 2021 Nov; 11(1):22932. PubMed ID: 34824352
[TBL] [Abstract][Full Text] [Related]
12. Serotonin transporters in dopamine transporter imaging: a head-to-head comparison of dopamine transporter SPECT radioligands 123I-FP-CIT and 123I-PE2I.
Ziebell M; Holm-Hansen S; Thomsen G; Wagner A; Jensen P; Pinborg LH; Knudsen GM
J Nucl Med; 2010 Dec; 51(12):1885-91. PubMed ID: 21078806
[TBL] [Abstract][Full Text] [Related]
13. Convolutional neural network based attenuation correction for
Chen Y; Goorden MC; Beekman FJ
Phys Med Biol; 2021 Sep; 66(19):. PubMed ID: 34492646
[TBL] [Abstract][Full Text] [Related]
14. Improved visual [(123)I]FP-CIT SPECT interpretation for evaluation of parkinsonism by visual rating of parametric distribution volume ratio images.
Meyer PT; Winz OH; Dafotakis M; Werner CJ; Krohn T; Schäfer WM
Q J Nucl Med Mol Imaging; 2011 Jun; 55(3):301-9. PubMed ID: 21532542
[TBL] [Abstract][Full Text] [Related]
15. Refining diagnosis of Parkinson's disease with deep learning-based interpretation of dopamine transporter imaging.
Choi H; Ha S; Im HJ; Paek SH; Lee DS
Neuroimage Clin; 2017; 16():586-594. PubMed ID: 28971009
[TBL] [Abstract][Full Text] [Related]
16. Reliability and validity of visual analysis of [ 18 F]FE-PE2I PET/CT in early Parkinsonian disease.
Af Bjerkén S; Axelsson J; Larsson A; Flygare C; Remes J; Strandberg S; Eriksson L; Bäckström D; Jakobson Mo S
Nucl Med Commun; 2023 May; 44(5):397-406. PubMed ID: 36862448
[TBL] [Abstract][Full Text] [Related]
17. Reduction in camera-specific variability in [(123)I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls.
Buchert R; Kluge A; Tossici-Bolt L; Dickson J; Bronzel M; Lange C; Asenbaum S; Booij J; Atay Kapucu LÖ; Svarer C; Koulibaly PM; Nobili F; Pagani M; Sabri O; Sera T; Tatsch K; Vander Borght T; Van Laere K; Varrone A; Iida H
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1323-36. PubMed ID: 26816194
[TBL] [Abstract][Full Text] [Related]
18. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies.
Koch W; Radau PE; Hamann C; Tatsch K
J Nucl Med; 2005 Jul; 46(7):1109-18. PubMed ID: 16000279
[TBL] [Abstract][Full Text] [Related]
19. Characterization of [123I]FP-CIT binding to the dopamine transporter in the striatum of tree shrews by quantitative in vitro autoradiography.
Geisler S; Beindorff N; Cremer M; Hoffmann K; Brenner W; Cumming P; Meyer PT; Langen KJ; Fuchs E; Buchert R
Synapse; 2015 Oct; 69(10):497-504. PubMed ID: 26126942
[TBL] [Abstract][Full Text] [Related]
20. The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases.
Sixel-Döring F; Liepe K; Mollenhauer B; Trautmann E; Trenkwalder C
J Neurol; 2011 Dec; 258(12):2147-54. PubMed ID: 21547379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
